跳至主要内容
临床试验/NCT01915953
NCT01915953Unknown不适用

A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP

OrSense, Ltd.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
发起方
OrSense, Ltd.
入组人数
500
试验地点
1
主要终点
compre the Hb values from the NBM200 series gainst the Hb from the lab blood analyser on Hematology pateints

研究概览

简要总结

The purpose of the study is to define the precision, accuracy and variability of the NBM-200 system in non invasive blood Hemoglobin (Hb) measurements relative to the laboratory blood analyzer by comparing two consecutive Hb values obtained by the NBM system to venous values.

详细描述

Each subject will be placed in a comfortable position in a temperature regulated room. Participants will have two consecutive non invasive (NBM) measurements taken which involves inserting the thumb into a ring shaped sensor. After each non invasive measurement the sensor will be removed. Each measurement takes approximately 85 seconds and involves the finger cuff inflating (to over systolic pressure) and deflating several times in quick successions in order to measure and calculate the Hb values. The two non invasive measurements will be performed using the same finger. After the NBM system testing is complete and recorded, the subject will have a venous (venipuncture) blood sample collected in order to provide two blood tests performed on two different models of routine automated complete blood count or Hb blood analyzers.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants aged 18 years and over

排除标准

  • Participants under the age of 18 years
  • Patients with significant deformity, degenerative changes or oedema of the fingers or hand
  • Patients with localized infection, ulceration or skin breaks involving the fingers
  • Patients with vascular disease or Raynaud's phenomenon affecting the fingers (vasospasm)
  • Participants who are unable to give informed written consent

结局指标

主要结局

compre the Hb values from the NBM200 series gainst the Hb from the lab blood analyser on Hematology pateints

时间窗: 1 day

次要结局

未报告次要终点

研究者

发起方
OrSense, Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Clinical Evaluation of the OrSense Non-invasive... | 临床试验